The 4 Youth by Youth (4YBY) pragmatic trial to enhance HIV self-testing uptake and sustainability: Study protocol in Nigeria.

HIV HIV self-testing Nigeria Participatory implementation strategies Sexually transmitted infections Stepped-wedge cluster-randomized controlled trial Youth

Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
03 2022
Historique:
received: 30 06 2021
revised: 11 11 2021
accepted: 14 11 2021
pubmed: 21 11 2021
medline: 1 4 2022
entrez: 20 11 2021
Statut: ppublish

Résumé

The World Health Organization recommends HIV self-testing (HIVST) as an additional approach to HIV testing and the Nigerian government is supportive of this policy recommendation. However, effectively increasing uptake and sustainability among Nigerian youth is unknown. The goal of this study is to conduct a full-powered type I hybrid effectiveness-implementation trial to test the effectiveness of youth-friendly implementation science strategies in increasing uptake and sustainability of HIVST led by and for Nigerian youth. Our 4 Youth by Youth (4YBY) strategy combines four core elements: 1) HIVST bundle consisting of HIVST kits and photo verification system; 2) a participatory learning community; 3) peer to peer support and technical assistance; and 4) on-site supervision and performance feedback to improve uptake and sustainability of HIVST and enhance linkage to youth-friendly health clinics for confirmatory HIV testing where needed, sexually transmitted infection (STI) testing (i.e. syphilis, gonorrhea, chlamydia, and hepatitis, STI treatment, and PrEP referral. Utilizing a stepped-wedge, cluster-randomized controlled trial, a national cohort of youth aged 14-24 recruited from 32 local government areas across 14 states and four geo-political zones in Nigeria will receive the 4YBY implementation strategy. In addition, an economic evaluation will explore the incremental cost per quality adjusted life year gained. This study will add to the limited "how-to-do it literature" on implementation science strategies in a resource-limited setting targeting youth population traditionally underrepresented in implementation science literature. Study findings will also optimize uptake and sustainability of HIVST led by and for young people themselves. This study is registered in ClinicalTrials.govNCT04710784 (on January 15, 2021).

Sections du résumé

BACKGROUND
The World Health Organization recommends HIV self-testing (HIVST) as an additional approach to HIV testing and the Nigerian government is supportive of this policy recommendation. However, effectively increasing uptake and sustainability among Nigerian youth is unknown. The goal of this study is to conduct a full-powered type I hybrid effectiveness-implementation trial to test the effectiveness of youth-friendly implementation science strategies in increasing uptake and sustainability of HIVST led by and for Nigerian youth.
METHODS
Our 4 Youth by Youth (4YBY) strategy combines four core elements: 1) HIVST bundle consisting of HIVST kits and photo verification system; 2) a participatory learning community; 3) peer to peer support and technical assistance; and 4) on-site supervision and performance feedback to improve uptake and sustainability of HIVST and enhance linkage to youth-friendly health clinics for confirmatory HIV testing where needed, sexually transmitted infection (STI) testing (i.e. syphilis, gonorrhea, chlamydia, and hepatitis, STI treatment, and PrEP referral. Utilizing a stepped-wedge, cluster-randomized controlled trial, a national cohort of youth aged 14-24 recruited from 32 local government areas across 14 states and four geo-political zones in Nigeria will receive the 4YBY implementation strategy. In addition, an economic evaluation will explore the incremental cost per quality adjusted life year gained.
DISCUSSION
This study will add to the limited "how-to-do it literature" on implementation science strategies in a resource-limited setting targeting youth population traditionally underrepresented in implementation science literature. Study findings will also optimize uptake and sustainability of HIVST led by and for young people themselves.
TRIAL REGISTRATION
This study is registered in ClinicalTrials.govNCT04710784 (on January 15, 2021).

Identifiants

pubmed: 34800699
pii: S1551-7144(21)00364-5
doi: 10.1016/j.cct.2021.106628
pmc: PMC9358609
mid: NIHMS1819569
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04710784']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106628

Subventions

Organisme : NICHD NIH HHS
ID : UG3 HD096929
Pays : United States
Organisme : NICHD NIH HHS
ID : UH3 HD096929
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

PLoS One. 2020 May 29;15(5):e0233698
pubmed: 32469971
J Int AIDS Soc. 2021 Feb;24(2):e25666
pubmed: 33569913
Lancet Glob Health. 2020 Feb;8(2):e276-e287
pubmed: 31981557
Implement Sci. 2012 May 24;7:48
pubmed: 22624776
Am J Community Psychol. 2010 Sep;46(1-2):67-83
pubmed: 20644994
EClinicalMedicine. 2020 Apr 18;21:100327
pubmed: 32322811
J Virus Erad. 2015 Jan;1(1):38-42
pubmed: 26005717
Adm Policy Ment Health. 2016 Jan;43(1):79-92
pubmed: 25542237
Qual Manag Health Care. 1998 Sep;6(4):1-13
pubmed: 10339040
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Implement Sci. 2018 Dec 27;13(1):154
pubmed: 30587195
J Community Psychol. 2020 May;48(4):1114-1131
pubmed: 32032448
Implement Sci. 2016 Mar 23;11:43
pubmed: 27005280
J Community Psychol. 2012 Apr 1;40(3):277-291
pubmed: 23843679
J Adolesc Health. 1999 Jul;25(1):7-13
pubmed: 10418879
Pediatr Res. 2016 Jun;79(6):838-45
pubmed: 26882367
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Curr HIV/AIDS Rep. 2011 Mar;8(1):62-72
pubmed: 20941553
Implement Sci. 2018 Jul 28;13(1):101
pubmed: 30055629
New Dir Youth Dev. 2009 Fall;2009(123):19-34, 11
pubmed: 19830799
Trials. 2017 Oct 2;18(1):447
pubmed: 28969702
J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):355-364
pubmed: 32195749
Trials. 2014 Feb 13;15:57
pubmed: 24524229
BMC Health Serv Res. 2019 Dec 27;19(1):1003
pubmed: 31881959
BMC Public Health. 2021 Jan 7;21(1):67
pubmed: 33413246
Health Promot Pract. 2020 Jul;21(4):573-581
pubmed: 30577698
Adv Child Dev Behav. 2016;50:189-207
pubmed: 26956074
Implement Sci. 2014 Jan 10;9:7
pubmed: 24410955
Trials. 2018 Mar 20;19(1):187
pubmed: 29558982
PLoS One. 2020 May 19;15(5):e0233368
pubmed: 32428005
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Reprod Health. 2017 Jan 31;14(1):16
pubmed: 28143542
BMC Infect Dis. 2014 Nov 25;14:601
pubmed: 25422065
Implement Sci. 2009 Oct 23;4:69
pubmed: 19852784
J Public Health Manag Pract. 2006 Nov;Suppl:S79-87
pubmed: 17035908
PLoS Med. 2012;9(7):e1001266
pubmed: 22815654
Jt Comm J Qual Patient Saf. 2018 Oct;44(10):566-573
pubmed: 30064957

Auteurs

Juliet Iwelunmor (J)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA. Electronic address: juliet.iwelunmor@slu.edu.

Joseph D Tucker (JD)

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Chisom Obiezu-Umeh (C)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA.

Titilola Gbaja-Biamila (T)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA; Clinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

David Oladele (D)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA; Clinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

Ucheoma Nwaozuru (U)

Department of Implementation Science, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Adesola Z Musa (AZ)

Clinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

Collins O Airhihenbuwa (CO)

Heath Policy and Behavioral Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA.

Kathryn Muessig (K)

Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Nora Rosenberg (N)

Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Rhonda BeLue (R)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA.

Hong Xian (H)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA.

Donaldson F Conserve (DF)

Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.

Jason J Ong (JJ)

Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Central Clinical School, Monash University, Melbourne, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia.

Lei Zhang (L)

Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia.

Jamie Curley (J)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA.

Susan Nkengasong (S)

Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.

Stacey Mason (S)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA.

Weiming Tang (W)

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Barry Bayus (B)

Kenan-Flagler Business School, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Gbenga Ogedegbe (G)

Center for Healthful Behavior Change, Division of Health and Behavior, Department of Population Health, New York University School of Medicine, NY, New York, USA.

Oliver Ezechi (O)

College for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA; Clinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH